drugset / Trial / NCT02323659
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety and quality of life in patients with primary cutaneous T-cell lymphomas after failure of topical or phototherapy treatment.
Timeline
- Start
- 2014-06-01
- Primary completion
- 2018-03
- Completion
- 2018-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 20 mg | Oral |
| Comparator | interferon alfa-2b | Protein / enzyme biologic | 3 iu | — |